Cardiocast

DOACs found safer than warfarin in the real world


 

The safety of direct oral anticoagulants is affirmed in a real-world study; a wearable ECG boosts atrial fibrillation detection by a factor of 8; new pediatric guidelines catch more hypertension cases in children; and nontraditional cardiovascular risk factors are not ready for prime time, says a federal task force. Listen to MDedge Cardiocast for all the details on the week’s top news, and subscribe on iTunes.

Recommended Reading

Impaired kidney function no problem for dabigatran reversal
MDedge Family Medicine
Does warfarin cause acute kidney injury?
MDedge Family Medicine
First reversal agent for apixaban and rivaroxaban gets fast-track approval
MDedge Family Medicine
Design limitations may have compromised DVT intervention trial
MDedge Family Medicine
DOAC’s edge over warfarin fades with low adherence
MDedge Family Medicine
Low vitamin D linked with DVT in lupus patients
MDedge Family Medicine
Canakinumab cut gout attacks in CANTOS
MDedge Family Medicine
New look at ATLAS suggests rivaroxaban may still have role in ACS
MDedge Family Medicine
DOJ lawsuit reins in inappropriate ICD use
MDedge Family Medicine
DOACs’ safety affirmed in real-world setting
MDedge Family Medicine